US Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

HGNS Treatment

The Apnex Hypoglossal Nerve Stimulation System (HGNS) is an implanted medical device that is designed to prevent the tongue from blocking the airway during sleep. It is fully automatic and can be implanted during a simple surgical procedure. After it is implanted, the device is programmed to meet the unique needs of each patient. The device is on when the patient is sleeping and off when the patient is awake.

Trial Locations (4)

10019

Clinilabs, Inc., New York

46260

Saint Vincent Hospital, Indianapolis

55455

University of Minnesota, Minneapolis

94143

University of California San Francisco, San Francisco

Sponsors
All Listed Sponsors
lead

Apnex Medical, Inc.

INDUSTRY

NCT01211444 - US Clinical Study of the Apnex Medical Hypoglossal Nerve Stimulation (HGNS) System to Treat Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter